Browsing "1. Journal Papers" by Author : 4120

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 14 of 14

This table browses all dspace content
Issue DateTitleJournal Title
2021Association between Fusobacterium nucleatum and patient prognosis in metastatic colon cancer SCIENTIFIC REPORTS
2024Chip collection of hepatocellular carcinoma based on O2 heterogeneity from patient tissue NATURE COMMUNICATIONS
2022Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation GUT AND LIVER
2021Clinical and survival outcomes after hepatectomy in patients with non-alcoholic fatty liver and hepatitis B-related hepatocellular carcinomaHPB
2020Clinicopathological characteristics of intrahepatic cholangiocarcinoma according to gross morphologic type: cholangiolocellular differentiation traits and inflammation- and proliferation-phenotypesHPB
2017Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibitionAUTOPHAGY
2016Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitisFREE RADICAL BIOLOGY AND MEDICINE
2020Gross Type of Hepatocellular Carcinoma Reflects the Tumor Hypoxia, Fibrosis, and Stemness-Related Marker ExpressionHEPATOLOGY INTERNATIONAL
2018Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice SCIENTIFIC REPORTS
2015Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular CarcinomaANNALS OF SURGICAL ONCOLOGY
2019Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis GUT AND LIVER
2020SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicityAUTOPHAGY
2024Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity EXPERIMENTAL AND MOLECULAR MEDICINE
2024Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progressionNATURE CANCER
1

Browse

Links